Clinically, dysregulation of the RANKL/OPG ratio is implicated in bone metabolic disorders such as osteoporosis, rheumatoid arthritis, and PPO (Jura-Półtorak et al., 2021). The gene discussed is TNFRSF11B; the disease is osteoporosis.